Mary Jenkins
Associate Director, Investor Relations
Replay available
Sarepta Therapeutics, Inc. (SRPT) Q1 2025 Earnings Call
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) Q1 2025 earnings conference call, held 2025-05-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Doug Ingram
President & CEO
Dallin Murray
Chief Customer Officer
Dr. Louise Rodino-Claypack
Head of R&D and Chief Scientific Officer
Ian Estepan
Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Sarepta Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.097 Good afternoon, and welcome to the Sarepta Therapeutics First Quarter 2025 Financial 00:00:05.097 -- 00:00:10.164 Results Conference Call. As a reminder, today's program is being recorded. 00:00:10.164 -- 00:00:15.070 At this time, I'll turn the call over to Mary Jenkins, Associate Director, Investor Relations. 00:00:15.070 -- 00:00:17.233 Please go ahead. 00:00:17.233 -- 00:00:20.096 Thank you, Marvin, and thank you all for joining today's call. 00:00:20.096 -- 00:00:24.989 Earlier this afternoon, we released our financial results for the first quarter of 2025. 00:00:24.989 -- 00:00:28.512 The press release slides and supplementary information are available on the investor 00:00:28.512 -- 00:00:34.178 section of our website at Sarepta.com, and our 10-Q was filed with the SEC this afternoon. 00:00:34.178 -- 00:00:38.702 Joining us on the call today are Doug Ingram, Ian Estepan, Dallin Murray, and Dr. 00:00:38.702 -- 00:00:41.044 Louise Rodino-Claypack. 00:00:41.044 -- 00:00:44.268 After our formal remarks, we'll open the call for Q&A. 00:00:44.268 -- 00:00:48.011 I'd like to note that during this call, we were making a number of forward-looking statements. 00:00:48.011 -- 00:00:52.394 Please refer to slide 2 on the webcast, which contains our forward-looking statements. 00:00:52.394 -- 00:00:56.198 These forward-looking statements involve risks and uncertainties, many of which are beyond 00:00:56.198 -- 00:01:00.462 Sarepta's control. Actual results could materially differ from these forward-looking 00:01:00.462 -- 00:01:05.147 statements, and any such risks can materially and adversely affect the business, the 00:01:05.147 -- 00:01:08.790 results of operations, and trading prices for Sarepta's common stock. 00:01:08.790 -- 00:01:1...